Elliott Charles Sigal

Affiliations

  • Director at Vir Biotechnology Inc. (VIR), 2025-06-02
  • Director at Alnylam Pharmaceuticals Inc. (ALNY), 2025-05-12
  • Director at Surface Oncology Inc. (SURF), 2023-09-08
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2023-07-03
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VIR $22.73 2,500 $56,815.50 10,000 2023-03-01 Filing
VIR $24.96 2,500 $62,395.50 7,500 2023-01-05 Filing
VIR $25.25 2,500 $63,136.25 5,000 2023-01-04 Filing
VIR $25.60 2,500 $63,992.50 2,500 2023-01-03 Filing
ADAP $1.56 15,000 $23,400.00 314,100 2016-05-19 Filing